CN108064152B - 包含氧基-氢氧化铜纳米颗粒的抗菌组合物及其作为杀生剂的用途 - Google Patents

包含氧基-氢氧化铜纳米颗粒的抗菌组合物及其作为杀生剂的用途 Download PDF

Info

Publication number
CN108064152B
CN108064152B CN201680037392.6A CN201680037392A CN108064152B CN 108064152 B CN108064152 B CN 108064152B CN 201680037392 A CN201680037392 A CN 201680037392A CN 108064152 B CN108064152 B CN 108064152B
Authority
CN
China
Prior art keywords
copper
nanoparticles
use according
oxo
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201680037392.6A
Other languages
English (en)
Chinese (zh)
Other versions
CN108064152A (zh
Inventor
卡洛斯·安德烈·帕索斯·巴斯托斯
希尔婉·弗朗索瓦丝·艾琳·布鲁格拉贝
努诺·若热·罗德里格斯·法里亚
乔纳森·约瑟夫·鲍威尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United Kingdom Research and Innovation
Original Assignee
Medical Research Council
United Kingdom Research and Innovation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council, United Kingdom Research and Innovation filed Critical Medical Research Council
Publication of CN108064152A publication Critical patent/CN108064152A/zh
Application granted granted Critical
Publication of CN108064152B publication Critical patent/CN108064152B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/30—Copper compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Urology & Nephrology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Materials For Medical Uses (AREA)
CN201680037392.6A 2015-04-24 2016-04-22 包含氧基-氢氧化铜纳米颗粒的抗菌组合物及其作为杀生剂的用途 Expired - Fee Related CN108064152B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1507002.2 2015-04-24
GBGB1507002.2A GB201507002D0 (en) 2015-04-24 2015-04-24 Copper Oxo-hydroxide nanoparticles and their uses as biocidal agents
PCT/EP2016/059074 WO2016170152A1 (en) 2015-04-24 2016-04-22 Antibacterial compositions comprising copper oxo-hydroxide nanoparticles and their uses as biocidal agents

Publications (2)

Publication Number Publication Date
CN108064152A CN108064152A (zh) 2018-05-22
CN108064152B true CN108064152B (zh) 2021-07-09

Family

ID=53488605

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201680037392.6A Expired - Fee Related CN108064152B (zh) 2015-04-24 2016-04-22 包含氧基-氢氧化铜纳米颗粒的抗菌组合物及其作为杀生剂的用途

Country Status (9)

Country Link
US (1) US20180147177A1 (enExample)
EP (1) EP3285759B1 (enExample)
JP (1) JP6775523B2 (enExample)
CN (1) CN108064152B (enExample)
CA (1) CA2983651A1 (enExample)
ES (1) ES2767651T3 (enExample)
GB (1) GB201507002D0 (enExample)
SG (1) SG11201708618WA (enExample)
WO (1) WO2016170152A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3789046A1 (en) 2019-09-05 2021-03-10 Nanordica Medical Oü Biocompatible nanoparticles with various surface functionalization for antimicrobial applications
US20240081336A1 (en) * 2019-09-16 2024-03-14 Corning Incorporated Color stabilization of biocidal coatings
US11247184B2 (en) 2019-12-30 2022-02-15 Marathon Petroleum Company Lp Methods and systems for spillback control of in-line mixing of hydrocarbon liquids
US11559774B2 (en) 2019-12-30 2023-01-24 Marathon Petroleum Company Lp Methods and systems for operating a pump at an efficiency point
US11607654B2 (en) 2019-12-30 2023-03-21 Marathon Petroleum Company Lp Methods and systems for in-line mixing of hydrocarbon liquids
CA3103413C (en) 2019-12-30 2023-04-25 Marathon Petroleum Company Lp Methods and systems for inline mixing of hydrocarbon liquids based on density or gravity
GB202005054D0 (en) 2020-04-06 2020-05-20 Nemysis Ltd Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions for Use in the Treatment or Prevention of Iron Deficiency Associated with Liver Diseases
CN111592032A (zh) * 2020-05-09 2020-08-28 山东科技大学 抗菌氢氧化铜纳米线膜及其制备方法及其二次利用方法
WO2021231702A1 (en) * 2020-05-15 2021-11-18 Rutgers, The State University Of New Jersey Compositions and methods for treating wounds
US12012883B2 (en) 2021-03-16 2024-06-18 Marathon Petroleum Company Lp Systems and methods for backhaul transportation of liquefied gas and CO2 using liquefied gas carriers
US11578836B2 (en) 2021-03-16 2023-02-14 Marathon Petroleum Company Lp Scalable greenhouse gas capture systems and methods
US11655940B2 (en) 2021-03-16 2023-05-23 Marathon Petroleum Company Lp Systems and methods for transporting fuel and carbon dioxide in a dual fluid vessel
US11578638B2 (en) 2021-03-16 2023-02-14 Marathon Petroleum Company Lp Scalable greenhouse gas capture systems and methods
US12129559B2 (en) 2021-08-26 2024-10-29 Marathon Petroleum Company Lp Test station assemblies for monitoring cathodic protection of structures and related methods
US11447877B1 (en) 2021-08-26 2022-09-20 Marathon Petroleum Company Lp Assemblies and methods for monitoring cathodic protection of structures
US12043905B2 (en) 2021-08-26 2024-07-23 Marathon Petroleum Company Lp Electrode watering assemblies and methods for maintaining cathodic monitoring of structures
US12180597B2 (en) 2021-08-26 2024-12-31 Marathon Petroleum Company Lp Test station assemblies for monitoring cathodic protection of structures and related methods
US11686070B1 (en) 2022-05-04 2023-06-27 Marathon Petroleum Company Lp Systems, methods, and controllers to enhance heavy equipment warning
CN116237532A (zh) * 2022-12-22 2023-06-09 江南大学 一种糖基配体类似物诱导手性钴基超小纳米粒子的合成方法
US12012082B1 (en) 2022-12-30 2024-06-18 Marathon Petroleum Company Lp Systems and methods for a hydraulic vent interlock
US12043361B1 (en) 2023-02-18 2024-07-23 Marathon Petroleum Company Lp Exhaust handling systems for marine vessels and related methods
US12006014B1 (en) 2023-02-18 2024-06-11 Marathon Petroleum Company Lp Exhaust vent hoods for marine vessels and related methods
US12297965B2 (en) 2023-08-09 2025-05-13 Marathon Petroleum Company Lp Systems and methods for mixing hydrogen with natural gas
US12220492B1 (en) 2023-09-08 2025-02-11 King Faisal University Wound dressing based on polymeric mixture of cellulose acetate and hyaluronic acid embedded with copper oxide and magnesium oxide nanoparticles
US12087002B1 (en) 2023-09-18 2024-09-10 Marathon Petroleum Company Lp Systems and methods to determine depth of soil coverage along a right-of-way

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164367A (en) * 1990-03-26 1992-11-17 Procyte Corporation Method of using copper(ii) containing compounds to accelerate wound healing
JP2004513905A (ja) * 2000-11-16 2004-05-13 ザイラー，　ケネス　ティー． 抗真菌爪用組成物および使用方法
AU2006314306A1 (en) * 2005-11-17 2007-05-24 Remedy Research Limited Pathogen - controlling products
NZ567962A (en) * 2006-04-24 2011-05-27 Nm Tech Ltd Nanomaterials And Microdevices Technology Functional nanomaterials with antibacterial and antiviral activity
US20080147019A1 (en) * 2006-12-19 2008-06-19 Kimberly-Clark Worldwide, Inc. Antimicrobial component system containing metallic nanoparticles and chitosan and/or its derivatives
EA019635B1 (ru) * 2007-02-06 2014-05-30 Медикал Ресёрч Каунсил Лиганд-модифицированные полиоксогидроксидные материалы с ионами металла, их применение и способы их получения
GB0702270D0 (en) * 2007-02-06 2007-03-14 Medical Res Council Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
IT1391668B1 (it) * 2008-07-23 2012-01-17 Universita' Degli Studi Di Trieste Materiali nanocompositi basati su nanoparticelle metalliche stabilizzate con polisaccaridi a struttura ramificata.
MX337197B (es) * 2009-11-06 2016-02-16 Carefusion 2200 Inc Sales de cobre de materiales de intercambio ionico para uso en el tratamiento y prevencion de infecciones.
GB201101299D0 (en) * 2011-01-25 2011-03-09 Medical Res Council Oxygen sensors and their uses
CN102631699A (zh) * 2011-02-11 2012-08-15 佛山市优特医疗科技有限公司 含有纳米金属的抗菌性纤维类敷料及其制备方法
AU2012258633A1 (en) * 2011-05-24 2013-11-28 Agienic, Inc. Compositions and methods for antimicrobial metal nanoparticles
GB201207617D0 (en) * 2012-05-02 2012-06-13 Systagenix Wound Man Ip Co Bv Wound dressings
US9255449B2 (en) * 2012-07-30 2016-02-09 Baker Hughes Incorporated Drill bit with electrohydraulically adjustable pads for controlling depth of cut
US10398733B2 (en) * 2013-03-15 2019-09-03 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the dermatological areas of the body
GB201402672D0 (en) * 2014-02-14 2014-04-02 Medical Res Council Materials and methods relating to stabilised polymeric silicate compositions

Also Published As

Publication number Publication date
EP3285759B1 (en) 2019-11-13
EP3285759A1 (en) 2018-02-28
HK1245642A1 (en) 2018-08-31
CA2983651A1 (en) 2016-10-27
JP6775523B2 (ja) 2020-10-28
CN108064152A (zh) 2018-05-22
US20180147177A1 (en) 2018-05-31
GB201507002D0 (en) 2015-06-10
ES2767651T3 (es) 2020-06-18
SG11201708618WA (en) 2017-11-29
WO2016170152A1 (en) 2016-10-27
JP2018513186A (ja) 2018-05-24

Similar Documents

Publication Publication Date Title
CN108064152B (zh) 包含氧基-氢氧化铜纳米颗粒的抗菌组合物及其作为杀生剂的用途
Zhou et al. Synthesis and characterization of silver nanoparticles-doped hydroxyapatite/alginate microparticles with promising cytocompatibility and antibacterial properties
Morsy et al. Development of hydroxyapatite-chitosan gel sunscreen combating clinical multidrug-resistant bacteria
AU2012267176B2 (en) Metal chelating compositions and methods for controlling the growth or activities of a living cell or organism
US7147845B2 (en) Antimicrobial silver ion complex resinates
CN1653907A (zh) 以高聚物为稳定剂的纳米银溶液和纳米银粉体的制备方法
MX2011011862A (es) Coposicion nanoestructural de biocida y proceso para obtener nanocomposicion biocida nanoestructural.
US20250114398A1 (en) Coated medicinal clay compositions, pharmaceutical compositions, and delivery of cation sources and methods of use thereof
US11000502B2 (en) Antimicrobial compositions comprising copper-hydroxypyrone complexes
US6923990B2 (en) Stabilized silver-ion amine complex compositions and methods
US20040214809A1 (en) Stabilized silver-ion sulfite complex compositions and methods
Gupta et al. Synthesis, characterization and concentration dependant antibacterial potentials of nickel oxide nanoparticles against Staphylococcus aureus and Escherichia coli
Khodke et al. Silver nanoparticles-A review
KR101796141B1 (ko) 다기능성 치료제 은 및 비타민 b6 착물, 이의 제조방법 및 이를 유효성분으로 함유하는 상처 치료용 약학적 조성물
HK1245642B (en) Antibacterial compositions comprising copper oxo-hydroxide nanoparticles and their preparation
WO2011160862A1 (en) Wound bandage with antimicrobic properties
JP3995052B1 (ja) 微生物増殖抑制作用を有するリン酸吸着性外用剤、それを含有する製品及びその製造方法
Basnet et al. Synergistic Effect of Tea-Phytochemicals, Noble Metals and ZnO Nano-Photo-Composites for Combating Resistance of Bacterial Growth
Lonny et al. Optimizing the Synergistic Antioxidant and Antibacterial Efficacy of Surface-Modified ZnO Nanoparticles for Chronic Wound Management
Ronchetti et al. Green Antibacterial Drug Delivery System-A Feasibility Study
US20230190788A1 (en) Method and process to make chitosan-doped strontium oxide nanocomposite for bactericidal applications

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right

Effective date of registration: 20200108

Address after: UK

Applicant after: United Kingdom Research and Innovation

Address before: Swindon, Wiltshire, UK

Applicant before: MEDICAL RESEARCH COUNCIL

TA01 Transfer of patent application right
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20210709

CF01 Termination of patent right due to non-payment of annual fee